ARGXargenxRunning, no new patients
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis
Myasthenia Gravis, Ocular
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 3
- Patients
- 141 (final count)
- Started
- Sep 18, 2024
- Main results expected
- Jan 12, 2026
- Fully finished
- Dec 2027
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
MGII (PRO) ocular score change from baseline to day 29 in part A
Measured over: Up to 29 days
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT06558279 · record last updated 2026-07-02 · checked 2026-11-09 15:47 UTC